~theguardian-world | Bookmarks (4)

Many firms see the dire forecasts as ‘overblown’ but they know they will have to adapt products to make ‘every bite must count’On a drizzly morning Luton’s takeaways are preparing for the lunchtime rush. McDonald’s is busy with shoppers, while chains from Subway to German Doner Kebab are opening their doors for the approaching army of hungry stomachs.The Bedfordshire town is one of the...

Pedro, five, was diagnosed with neuroblastoma; a fund has been set up so that his family can afford expensive chemotherapy drugLeading artists, Indigenous activists and politicians across Brazil are urging people to contribute to a fund to help the son of the slain Amazon activist Bruno Pereira, who has been diagnosed with a rare form of cancer.Pedro Pereira, five, the son of anthropologist Beatriz...

State will be first to import drugs under federal program that Florida governor says could save consumers $150m in first yearA public health policy that won rare backing from both the Biden and Trump administrations looks ready to open a flow of cheaper prescription drugs from Canada to Florida, ending a decades-long block on the importation of certain pharmaceuticals to the US.The federal Food...

Gracell Biotechnologies acquisition marks China’s growing importance to the Anglo-Swedish drugmakerAstraZeneca has struck a deal to buy a Chinese cancer therapy company for up to $1.2bn (£950m), as Britain’s biggest drugmaker expands its footprint in its second-largest market.The Anglo-Swedish pharmaceutical firm announced on Tuesday it would acquire Gracell Biotechnologies, which is focused on a type of cancer therapy known as CAR-T that modifies a...